Risk factors for postoperative pulmonary infections in non-small cell lung cancer: a regression-based nomogram prediction model.

IF 3.6 3区 医学 Q2 ONCOLOGY
American journal of cancer research Pub Date : 2024-11-15 eCollection Date: 2024-01-01 DOI:10.62347/BIBD8425
Chao Zhang, Yongxing Fu, Qiangjun Chen, Ruofan Liu
{"title":"Risk factors for postoperative pulmonary infections in non-small cell lung cancer: a regression-based nomogram prediction model.","authors":"Chao Zhang, Yongxing Fu, Qiangjun Chen, Ruofan Liu","doi":"10.62347/BIBD8425","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To identify key risk factors for postoperative pulmonary infections (PPIs) in lung cancer (LC), patients undergoing radical surgery and construct a multiparametric nomogram model to improve PPI risk prediction accuracy, guiding individualized interventions.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on LC patients treated at Yidu Central Hospital of Weifang from March 2020 to May 2023. Among the 1,084 LC cases reviewed, patients were divided into an infected group (n = 131) and an uninfected group (n = 953) based on infection status. Key factors for PPIs were screened using machine learning techniques, including least absolute shrinkage and selection operator (LASSO) regression, Support Vector Machine (SVM), and Extreme Gradient Boosting (XGBoost). A nomogram prediction model was developed, and its stability and clinical utility were evaluated using calibration curves and decision curve analysis, with internal validation through random case selection.</p><p><strong>Results: </strong>Thirteen factors - including tumor stage, diabetes history, chronic obstructive pulmonary disease (COPD), operation duration, mechanical ventilation duration, age, C-reactive protein, procalcitonin, high-mobility group box 1, interleukin-6, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index - were identified as significantly associated with PPIs. The nomogram model demonstrated high predictive accuracy in internal validation (C-index = 0.935), strong calibration, and substantial clinical benefit. For two randomly selected cases, the model predicted a 63% infection probability for the infected patient and a 32% probability for the uninfected patient, affirming the model's predictive effectiveness.</p><p><strong>Conclusions: </strong>The multiparametric nomogram model developed in this study provides a reliable method for PPI risk prediction in LC patients, supporting clinical decision-making and improving postoperative management.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 11","pages":"5365-5377"},"PeriodicalIF":3.6000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626275/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/BIBD8425","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To identify key risk factors for postoperative pulmonary infections (PPIs) in lung cancer (LC), patients undergoing radical surgery and construct a multiparametric nomogram model to improve PPI risk prediction accuracy, guiding individualized interventions.

Methods: A retrospective analysis was conducted on LC patients treated at Yidu Central Hospital of Weifang from March 2020 to May 2023. Among the 1,084 LC cases reviewed, patients were divided into an infected group (n = 131) and an uninfected group (n = 953) based on infection status. Key factors for PPIs were screened using machine learning techniques, including least absolute shrinkage and selection operator (LASSO) regression, Support Vector Machine (SVM), and Extreme Gradient Boosting (XGBoost). A nomogram prediction model was developed, and its stability and clinical utility were evaluated using calibration curves and decision curve analysis, with internal validation through random case selection.

Results: Thirteen factors - including tumor stage, diabetes history, chronic obstructive pulmonary disease (COPD), operation duration, mechanical ventilation duration, age, C-reactive protein, procalcitonin, high-mobility group box 1, interleukin-6, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index - were identified as significantly associated with PPIs. The nomogram model demonstrated high predictive accuracy in internal validation (C-index = 0.935), strong calibration, and substantial clinical benefit. For two randomly selected cases, the model predicted a 63% infection probability for the infected patient and a 32% probability for the uninfected patient, affirming the model's predictive effectiveness.

Conclusions: The multiparametric nomogram model developed in this study provides a reliable method for PPI risk prediction in LC patients, supporting clinical decision-making and improving postoperative management.

非小细胞肺癌术后肺部感染的危险因素:基于回归的nomogram预测模型
目的:识别肺癌(LC)根治性手术患者术后肺部感染(PPIs)的关键危险因素,构建多参数nomogram模型,提高PPI风险预测准确率,指导个体化干预。方法:回顾性分析潍坊市宜都中心医院2020年3月至2023年5月收治的LC患者。在1084例LC病例中,根据感染情况将患者分为感染组(n = 131)和未感染组(n = 953)。使用机器学习技术筛选ppi的关键因素,包括最小绝对收缩和选择算子(LASSO)回归、支持向量机(SVM)和极端梯度增强(XGBoost)。建立了nomogram预测模型,通过校准曲线和决策曲线分析对模型的稳定性和临床应用进行了评价,并通过随机病例选择进行了内部验证。结果:肿瘤分期、糖尿病史、慢性阻塞性肺疾病(COPD)、手术时间、机械通气时间、年龄、c反应蛋白、降钙素原、高迁移率组1、白细胞介素-6、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、全身免疫炎症指数等13个因素与PPIs有显著相关性。nomogram模型在内部验证中具有较高的预测准确度(C-index = 0.935)、较强的校准性和可观的临床效益。对于随机选择的两个病例,该模型预测感染患者的感染概率为63%,未感染患者的感染概率为32%,证实了该模型的预测有效性。结论:本研究建立的多参数nomogram模型为LC患者PPI风险预测提供了可靠的方法,可支持临床决策,改善术后管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
3.80%
发文量
263
期刊介绍: The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who are devoted to the promotion and advancement of our understanding of the cancer and its treatment. The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline where the primary focus of the research is to increase and integrate knowledge about etiology and molecular mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor. Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to retain our comfortable familiarity towards an academic journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信